Who is likely to stop psoriasis treatment? New evidence reveals all…
Women and people who are obese are more likely to stop taking biologic drugs for psoriasis, says a study in the British Journal of Dermatology. But those who have psoriatic arthritis are more likely to stick at the treatment.
We know that long-term treatment of psoriasis is hindered by people discontinuing treatment so researchers set out to establish what factors predict who will stop taking the medication. They included data from over 30,000 people and discovered that obesity and being female predicted treatment discontinuation. But having psoriatic arthritis predicted persisting with the biologic drugs. Women tended to stop taking the treatment because of side effects.
The team concludes that “our analysis demonstrates that female sex and obesity predicts biologic discontinuation, and concomitant psoriatic arthritis predicts biologic survival”. The research is important because it gives healthcare professionals an insight about which patients might need more information and support.
Click here to read the original research.
Arthritis Digest Magazine was selected by Feedspot as one of the Top 5 Arthritis Blogs on the internet in 2018.
For more in-depth features, interviews and information, subscribe to Arthritis Digest magazine, a popular title that’s published six times a year. Click here for the digital version or tel 0845 643 8470 to order your had copy. You’ll know what your doctor is talking about, what new drugs are in the pipeline and be up to date on helpful products.